Laurel Douty - 16 Feb 2021 Form 4 Insider Report for Signify Health, Inc.

Signature
/s/ Adam McAnaney, as Attorney-in-Fact for Laurel Douty
Issuer symbol
N/A
Transactions as of
16 Feb 2021
Net transactions value
+$240,000
Form type
4
Filing time
09 Mar 2022, 16:54:25 UTC

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGFY Class A Common Stock Purchase $240,000 +10,000 $24.00 10,000 16 Feb 2021 Direct F1
transaction SGFY Class A Common Stock Award $0 +44,046 +440% $0.000000 54,046 07 Mar 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGFY Employee Stock Option (Right to Buy) Award $0 +132,138 $0.000000 132,138 07 Mar 2022 Class A Common Stock 132,138 $14.19 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities were purchased through the Issuer's directed share program in connection with its initial public offering.
F2 Represents a grant of restricted stock units on March 7, 2022 that will vest in equal annual installments on each of the first four anniversaries of the grant date.
F3 These options vest in equal annual installments on each of the first four anniversaries of the March 7, 2022 grant date.